Published in Ann Clin Lab Sci on January 30, 1973
Selective trafficking of KNOTTED1 homeodomain protein and its mRNA through plasmodesmata. Science (1995) 4.40
The nature and control of infections in patients with acute leukemia. Cancer Res (1965) 2.55
Detection of measles virus RNA in paraffin-embedded tissue. Lancet (1989) 1.32
A new inherited coagulation disorder caused by an abnormal fibrinogen ('fibrinogen Baltimore'). Nature (1965) 1.18
Thrombocytopenic purpura following rubella infection in children and adults. Arch Intern Med (1966) 1.05
Labile coagulation factors in thawed fresh frozen plasma prepared by two methods. Vox Sang (1984) 1.00
Congenital agranulocytosis: prolonged survival and terminal acute leukemia. Blood (1970) 1.00
Congenital disorders of fibrinogen. Fed Proc (1965) 1.00
Labyrinthine pattern formation in magnetic fluids. Science (1993) 0.99
Automated fibrinogen determination. Am J Clin Pathol (1971) 0.98
Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae. J Clin Invest (1995) 0.93
Glucose-6-phosphate dehydrogenase deficiency and blood transfusion. Vox Sang (1975) 0.92
Effects of arvin on blood platelets. In vitro and in vivo studies. J Lab Clin Med (1972) 0.90
Preliminary report on the use of hydroxyethyl starch solution in man. J Surg Res (1966) 0.89
Factor V activity in fresh frozen and cryoprecipitate-removed plasma. Vox Sang (1972) 0.87
Characterization of murine hepatitis virus (JHM) RNA from rats with experimental encephalomyelitis. Virology (1984) 0.87
Isolation and sequence analysis of the Pseudomonas syringae pv. tomato gene encoding a 2,3-diphosphoglycerate-independent phosphoglyceromutase. J Bacteriol (1995) 0.86
Activation of int-1 and int-2 loci in GRf mammary tumors. Virology (1986) 0.85
Post-transfusion thrombocytopenic purpura. Johns Hopkins Med J (1967) 0.85
[Hemorrhagic diathesis with dominant heredity, caused by an abnormal fibrinogen (fibrinogen Baltimore)]. Schweiz Med Wochenschr (1966) 0.85
A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma. Br J Cancer (2006) 0.84
Functional evaluation of an inherited abnormal fibrinogen: fibrinogen "Baltimore". J Clin Invest (1971) 0.82
Analysis of JHM central nervous system infections in rats. Arch Neurol (1986) 0.81
Utilization of trehalose during Dictyostelium discoideum spore germination. Dev Biol (1982) 0.80
HIV-associated autoimmune hemolytic anemia complicated by pulmonary embolism following a red blood cell transfusion: case report and review of the literature. Conn Med (1998) 0.80
Nickel-induced erythrocytosis: efficacies of nickel compounds and susceptibilities of rat strains. Ann Clin Lab Sci (1978) 0.79
Dose-response and time-response study of erythrocytosis in rats after intrarenal injection of nickel subsulfide. Ann Clin Lab Sci (1977) 0.78
Iron deficiency and anemia of chronic disease in elderly women: a discriminant-analysis approach for differentiation. Am J Clin Nutr (1995) 0.78
Studies on the degradation of human fibrinogen by plasmin and trypsin. Thromb Diath Haemorrh (1966) 0.78
Analysis of two types of granulocyte transfusions in patients with acute leukemia and septicemia. Ann Clin Lab Sci (1982) 0.77
Exchange transfusion with red blood cells preserved in adenine clears a child of severe falciparum malaria. Ann Clin Lab Sci (1997) 0.77
Increased serum erythropoietin activity in rats following intrarenal injection of nickel subsulfide. Res Commun Chem Pathol Pharmacol (1979) 0.77
Ah Receptor Pathway Intricacies; Signaling Through Diverse Protein Partners and DNA-Motifs. Toxicol Res (Camb) (2015) 0.77
Effects of intrarenal injection of nickel subsulfide in rodents. Ann Clin Lab Sci (1980) 0.77
Fibrinogen and the fibrinogenopathies. Ann Clin Lab Sci (1973) 0.76
Hereditary disorders of blood coagulation due to defective and deficient synthesis of protein. Trans Am Clin Climatol Assoc (1971) 0.75
Evaluation of iron status in women identified by copper sulfate screening as ineligible to donate blood. Transfusion (1987) 0.75
Affirmative action for the handicapped and veterans: interpretative and operational guidelines. Labor Law J (1978) 0.75
An in vitro test of platelet viability. Johns Hopkins Med J (1980) 0.75
Platelet collection and transfusion using the fenwal CS-3000 cell separator. Transfusion (1981) 0.75
Hemorrhagic disease. Md State Med J (1968) 0.75
Treatment of thrombotic thrombocytopenic purpura. Evaluation of plasma exchange and review of the literature. Vox Sang (1983) 0.75
Effects of reptilase and thrombin on human blood platelets and observations on the molecular mechanism of clot retraction. J Lab Clin Med (1967) 0.75
Business or service? Ann Clin Lab Sci (1992) 0.75
Characteristics and natural history of alloimmunization following HLA-matched leukocyte transfusion in Hunter's syndrome. Ann Clin Lab Sci (1984) 0.75
Platelet viability following storage for 5 days. Influence of holding whole blood for 8 hours at 20 to 24 degrees C before concentrate preparation. Transfusion (1984) 0.75
The granulocyte nitroblue tetrazolium reductase test. Ann Clin Lab Sci (1974) 0.75
Determination of fibrinogen in plasma. Ann Clin Lab Sci (1978) 0.75
Conjoint clinic on thrombophlebitis. J Chronic Dis (1966) 0.75
Fibrinogen and dysfibrinogenemia. Ann Clin Lab Sci (1981) 0.75
Autologous blood: a better product. Conn Med (1987) 0.75
Acquired pyruvate kinase deficiency. Ann Clin Lab Sci (1977) 0.75
Effects of drugs on platelet function. Ann Clin Lab Sci (1977) 0.75
Decreased ionized calcium during therapeutic plasma exchange pheresis and platelet pheresis. Johns Hopkins Med J (1980) 0.75
Blood component therapy. Conn Med (1969) 0.75
The fibrinogenopathies. Ann Clin Lab Sci (1978) 0.75
Interdonor incompatibility as a cause of reaction during granulocyte transfusion. Vox Sang (1978) 0.75
Use of frozen blood. Ann Clin Lab Sci (1974) 0.75
Chromium-51 release from human blood platelets by anti A antibody. Ann Clin Lab Sci (1975) 0.75
Clinical effectiveness of transfusion of granulocytes obtained by filtration or intermittent flow centrifugation. Cancer (1981) 0.75
The International Normalized Ratio: a dispassionate view. Ann Clin Lab Sci (1993) 0.75
Elution of filtered granulocytes for transfusion. Ann Clin Lab Sci (1977) 0.75
The use of leukocyte acid phosphatase in the diagnosis of malignant disease. Case report and review of literature. Ann Clin Lab Sci (1980) 0.75
Treatment of disorders of blood platelets. Mod Treat (1968) 0.75
Inhibition of bacterial growth by granulocytes measured by an automated technique. Ann Clin Lab Sci (1980) 0.75
Therapeutic plasmapheresis in patients with renal disease. Ann Clin Lab Sci (1981) 0.75
Indications for platelet transfusions. Md State Med J (1968) 0.75
Electronic data processing as an aid to statewide blood management. Transfusion (1972) 0.75
Consequences of erythropoietin production by neoplasms. Ann Clin Lab Sci (1979) 0.75
Influence of plasma source on T-lymphocyte subpopulations in hemophiliacs using factor VIII concentrate. N Engl J Med (1983) 0.75
Trends in hepatitis B surface antigen (HBsAg) prevalence in volunteer blood donors in Connecticut, 1973-1983. Ann Clin Lab Sci (1986) 0.75
Chronic knee pain in a 35-year-old man. Invest Radiol (1981) 0.75
Erythrocyte fragmentation in defibrination syndromes. Ann Intern Med (1974) 0.75
Clinical and serological findings in alloimmune neonatal thrombocytopenia. Conn Med (1986) 0.75
Clinical interpretations of the measurement of folic acid and vitamin B12 in neuromuscular disease. Ann Clin Lab Sci (1976) 0.75
Can clinical science survive? Ann Clin Lab Sci (1981) 0.75
Preparation of young red cells for transfusion using the Fenwal CS 3000 cell separator. Am J Hematol (1984) 0.75
Distribution of fresher blood in a statewide blood program. Transfusion (1974) 0.75
HLA alloimmunization with leukocyte concentrates from HLA-matched and HLA-non-matched donors in patients with Hunter's syndrome. Ann Clin Lab Sci (1985) 0.75
Factors affecting the efficiency of filtration leukapheresis. Transfusion (1977) 0.75
Increased electronic mean corpuscular volume induced by marked hyperglycemia. Ann Clin Lab Sci (1981) 0.75
Iron supplementation in female blood donors deferred by copper sulfate screening. Transfusion (1988) 0.75
Survey of blood use in Baltimore. Md State Med J (1968) 0.75
Platelet filters--an evaluation. Transfusion (1972) 0.75
Granulocyte yields using the Haemonetics 30. Effects of variations in corticosteroid regimen and donor selection. Vox Sang (1982) 0.75
An improved method for the quantitation of A2 hemoglobin utilizing cellulose acetate electrophoresis and densitometry. Am J Clin Pathol (1975) 0.75
Clinical effectiveness of granulocyte transfusions. Conn Med (1979) 0.75
Use of terminal deoxynucleotidyl transferase in the diagnosis of leukemia. Ann Clin Lab Sci (1983) 0.75
Design technology: programming user needs. J Healthc Des (1992) 0.75